BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Zhang W, Guo Q, Chen L, Meng Z, Xu Y, Cao N, Hu B, Qian B. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia. Front Surg 2021;8:755957. [PMID: 34733883 DOI: 10.3389/fsurg.2021.755957] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Laganà A, Di Lascio G, Di Blasi A, Licari LC, Tufano A, Flammia RS, De Carolis A. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience. World J Urol 2023. [PMID: 36853444 DOI: 10.1007/s00345-023-04322-1] [Reference Citation Analysis]
2 Tafuri A, Panunzio A, De Carlo F, Luperto E, Di Cosmo F, Cavaliere A, Rizzo M, Tian Z, Shakir A, De Mitri R, Porcaro AB, Cerruto MA, Antonelli A, Cormio L, Carrieri G, Karakiewicz PI, Abreu AL, Pagliarulo V. Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies. J Clin Med 2023;12. [PMID: 36902647 DOI: 10.3390/jcm12051860] [Reference Citation Analysis]
3 Lorenzoni V, Palla I, Manenti G, Ditonno P, de Reijke TM, Turchetti G. Standard approach and future perspective for the management of benign prostatic hyperplasia from a health-economics point of view: the role of transperineal laser ablation. Front Urol 2023;3. [DOI: 10.3389/fruro.2023.1100386] [Reference Citation Analysis]
4 Sessa F, Polverino P, Siena G, Bisegna C, Lo Re M, Spatafora P, Pecoraro A, Rivetti A, Moscardi L, Saladino M, Cocci A, Gacci M, Li Marzi V, Carini M, Minervini A, Campi R, Serni S. Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction. J Clin Med 2023;12. [PMID: 36769454 DOI: 10.3390/jcm12030793] [Reference Citation Analysis]
5 Chen L, Zhang W, Meng Z, Guo Q, Cao N, Xu Y, Fu Q, Hu B. Efficacy and safety of ultrasonography guided transperineal percutaneous laser ablation for treating benign prostatic hyperplasia: a randomized controlled trial.. [DOI: 10.21203/rs.3.rs-2433606/v1] [Reference Citation Analysis]
6 Lotfy MA, Salman SA. Evaluation of efficacy and safety of intraoperative tranexamic acid: prospective placebo-controlled comparative study. Egyptian Journal of Anaesthesia 2022;38:491-496. [DOI: 10.1080/11101849.2022.2113703] [Reference Citation Analysis]
7 Sessa F, Bisegna C, Polverino P, Gacci M, Siena G, Cocci A, Marzi VL, Minervini A, Serni S, Campi R. Transperineal laser ablation of the prostate (TPLA) for selected patients with lower urinary tract symptoms due to benign prostatic obstruction: a step-by-step guide. Urology Video Journal 2022;15:100167. [DOI: 10.1016/j.urolvj.2022.100167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sessa F, Polverino P, Bisegna C, Siena G, Lo Re M, Spatafora P, Pecoraro A, Rivetti A, Conte FL, Cocci A, Villari D, Minervini A, Gacci M, Li Marzi V, Serni S, Campi R. Transperineal laser ablation of the prostate with EchoLaser™ system: perioperative and short-term functional and sexual outcomes. Front Urol 2022;2. [DOI: 10.3389/fruro.2022.969208] [Reference Citation Analysis]
9 Jin S, Liu Z, Liu Y, Wu J, Yu Q. Analysis of Risk Factors and Nursing Strategies for Postoperative Hemorrhage of Benign Prostatic Hyperplasia. Evid Based Complement Alternat Med 2022;2022:4205015. [PMID: 35646136 DOI: 10.1155/2022/4205015] [Reference Citation Analysis]